Banco de Sabadell’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.73M | Sell |
4,214
-331
| -7% | -$336K | 2.48% | 12 |
|
|
2025
Q4 | $4.88M | Sell |
4,545
-98
| -2% | -$93.7K | 3.18% | 7 |
|
|
2025
Q3 | $3.54M | Sell |
4,643
-37
| -0.8% | -$27.5K | 2.34% | 12 |
|
|
2025
Q2 | $3.65M | Sell |
4,680
-142
| -3% | -$110K | 2.52% | 10 |
|
|
2025
Q1 | $3.98M | Buy |
4,822
+289
| +6% | +$240K | 3.03% | 8 |
|
|
2024
Q4 | $3.5M | Buy |
4,533
+143
| +3% | +$118K | 2.75% | 12 |
|
|
2024
Q3 | $3.89M | Sell |
4,390
-143
| -3% | -$129K | 2.91% | 7 |
|
|
2024
Q2 | $4.1M | Sell |
4,533
-88
| -2% | -$70.4K | 3.01% | 6 |
|
|
2024
Q1 | $3.6M | Sell |
4,621
-288
| -6% | -$205K | 2.68% | 8 |
|
|
2023
Q4 | $2.86M | Sell |
4,909
-74
| -1% | -$43.2K | 2.17% | 11 |
|
|
2023
Q3 | $2.68M | Sell |
4,983
-382
| -7% | -$197K | 2.33% | 10 |
|
|
2023
Q2 | $2.51M | Sell |
5,365
-1,344
| -20% | -$564K | 2.02% | 12 |
|
|
2023
Q1 | $2.3M | Buy |
6,709
+451
| +7% | +$152K | 1.92% | 16 |
|
|
2022
Q4 | $2.29M | Sell |
6,258
-1,353
| -18% | -$480K | 1.92% | 21 |
|
|
2022
Q3 | $2.46M | Buy |
7,611
+94
| +1% | +$29.8K | 2.04% | 12 |
|
|
2022
Q2 | $2.44M | Sell |
7,517
-1,328
| -15% | -$399K | 2.05% | 17 |
|
|
2022
Q1 | $2.53M | Buy |
8,845
+406
| +5% | +$104K | 1.46% | 26 |
|
|
2021
Q4 | $2.33M | Buy |
8,439
+1,198
| +17% | +$304K | 1.31% | 31 |
|
|
2021
Q3 | $1.68M | Sell |
7,241
-54
| -0.7% | -$13.3K | 1.13% | 42 |
|
|
2021
Q2 | $1.68M | Sell |
7,295
-31,789
| -81% | -$6.39M | 1.12% | 42 |
|
|
2021
Q1 | $7.28M | Buy |
39,084
+16,766
| +75% | +$3.28M | 0.75% | 35 |
|
|
2020
Q4 | $3.75M | Sell |
22,318
-3,007
| -12% | -$449K | 0.4% | 74 |
|
|
2020
Q3 | $3.74M | Sell |
25,325
-11,612
| -31% | -$1.8M | 0.42% | 60 |
|
|
2020
Q2 | $6.04M | Buy |
36,937
+29,209
| +378% | +$4.48M | 0.79% | 32 |
|
|
2020
Q1 | $1.07M | Sell |
7,728
-1,039
| -12% | -$143K | 0.17% | 137 |
|
|
2019
Q4 | $1.15M | Sell |
8,767
-276
| -3% | -$32K | 0.15% | 147 |
|
|
2019
Q3 | $1.01M | Sell |
9,043
-9,517
| -51% | -$1.06M | 0.14% | 152 |
|
|
2019
Q2 | $2.06M | Sell |
18,560
-177
| -0.9% | -$20.8K | 0.24% | 115 |
|
|
2019
Q1 | $2.43M | Sell |
18,737
-1,145
| -6% | -$139K | 0.32% | 84 |
|
|
2018
Q4 | $2.27M | Sell |
19,882
-13,928
| -41% | -$1.56M | 0.28% | 88 |
|
|
2018
Q3 | $3.62M | Sell |
33,810
-3,544
| -9% | -$354K | 0.4% | 58 |
|
|
2018
Q2 | $3.19M | Buy |
37,354
+20,271
| +119% | +$1.66M | 0.41% | 56 |
|
|
2018
Q1 | $1.32M | Buy |
17,083
+1,372
| +9% | +$110K | 0.16% | 142 |
|
|
2017
Q4 | $1.33M | Buy |
+15,711
| New | +$1.34M | 0.17% | 128 |
|
Other funds holding LLY
VCM
VPM
Banco de Sabadell's LLY Position: Q1 2026 in Review
Banco de Sabadell reduced its Eli Lilly (LLY) stake by 7.3% in Q1 2026, selling an estimated $336K and leaving 4,214 shares worth $3.73M. The position accounts for 2.48% of the portfolio, ranked #12.
Banco de Sabadell first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $7.28M in Q1 2021. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Banco de Sabadell held 4,214 shares of Eli Lilly worth $3.73M as of Q1 2026.
- Banco de Sabadell sold 331 Eli Lilly shares in Q1 2026, an estimated $336K.
- Eli Lilly made up 2.48% of Banco de Sabadell's portfolio in Q1 2026, its #12 holding.
- Banco de Sabadell first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- Banco de Sabadell's Eli Lilly position peaked at $7.28M in Q1 2021.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Banco de Sabadell's 13F filing for Q1 2026, filed 8 May 2026.